Héma-Québec studies

SEROPREVALENCE STUDY

A study conducted by Héma-Québec, in collaboration with Québec public health authorities, aims to measure the progression of immunity in the population.

CLINICAL STUDY ON CONVALESCENT PLASMA

Héma-Québec was involved in a national clinical trial project, with the objective of developing a passive immunization program for treating people with COVID-19.

PLASCOV PROJECT

The study aims to measure the impact of vaccination, or infection, on the immune response.